Last edition
News about "respiratory viruses"
Vicebio Raises USD 100 Million in Series B Financing Round
Vicebio is developing next-generation vaccines for respiratory viruses utilising its proprietary Molecular Clamp technology, discovered at The University of Queensland.
Respiratory Viruses | 23/09/2024 | By Aishwarya | 127
Sanofi Signs Co-Exclusive Licensing Deal with Novavax to Co-Commercialize COVID-19 Vaccine
Sanofi has signed a co-exclusive licensing agreement with Novavax, a biotechnology company headquartered in Maryland, US.
Respiratory Viruses | 10/05/2024 | By Aishwarya | 101
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy